MT-ND5 and Alzheimer disease: It has been shown that RNA modifications, specifically, N1-methylation of adenosine in the NADH dehydrogenase subunit 5 (ND5) mRNA, disrupt mitochondrial protein synthesis, leading to mitochondrial complex I dysfunction in AD patients [17].